- Home
- FC vs SLGL Comparison
FC vs SLGL Comparison
Compare FC & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FC | SLGL |
|---|---|---|
| Founded | 1983 | 1997 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.2M | 247.1M |
| IPO Year | 1994 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FC | SLGL |
|---|---|---|
| Price | $21.89 | $64.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $26.00 | ★ $110.00 |
| AVG Volume (30 Days) | ★ 58.1K | 13.6K |
| Earning Date | 04-01-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $267,067,000.00 | N/A |
| Revenue This Year | $3.15 | N/A |
| Revenue Next Year | $4.04 | $223.84 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.16 | $6.80 |
| 52 Week High | $24.70 | $97.97 |
Technical Indicators
Market Signals| Indicator | FC | SLGL |
|---|---|---|
| Relative Strength Index (RSI) | 56.56 | 40.03 |
| Support Level | $18.63 | $61.92 |
| Resistance Level | $23.90 | $67.85 |
| Average True Range (ATR) | 1.09 | 5.06 |
| MACD | -0.24 | -0.73 |
| Stochastic Oscillator | 60.29 | 3.77 |
Price Performance
Historical ComparisonAbout FC Franklin Covey Company
Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.